Search hospitals > Tennessee > Nashville
Tennessee Oncology PLLC
Claim this profileNashville, Tennessee 37203
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cystic Tumor
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Solid Tumors
296 reported clinical trials
11 medical researchers
Summary
Tennessee Oncology PLLC is a medical facility located in Nashville, Tennessee. This center is recognized for care of Breast Cancer, Lung Cancer, Cystic Tumor, Non-Small Cell Lung Cancer, Solid Tumors and other specialties. Tennessee Oncology PLLC is involved with conducting 296 clinical trials across 179 conditions. There are 11 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and David R. Spigel, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
2Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Melissa Johnson, MDSarah Cannon Research Institute6 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
66 reported clinical trials
94 drugs studied
Erika P HamiltonSarah Cannon Research Institute5 years of reported clinical research
Expert in Breast Cancer
Expert in Ovarian Cancer
55 reported clinical trials
77 drugs studied
Meredith A McKeanSarah Cannon Research Institute1 year of reported clinical research
Expert in Solid Tumors
Expert in Cystic Tumor
35 reported clinical trials
67 drugs studied
David R. Spigel, MDTennessee Oncology4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
29 reported clinical trials
54 drugs studied
Clinical Trials running at Tennessee Oncology PLLC
Breast Cancer
Solid Tumors
Lymphoma
Lung Cancer
Cancer
Cystic Tumor
Non-Small Cell Lung Cancer
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Ovarian Cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting2 awards Phase 33 criteria
BT5528
for Solid Cancers
This clinical trial is evaluating a drug called BT5528 alone and in combination with nivolumab in participants with advanced solid tumors historically known for expression of EphA2. The main goals of this study are to: * Find the recommended dose(s) of BT5528 that can be given safely to participants alone and in combination with nivolumab * Learn more about the side effects of BT5528 * Learn about how effective BT5528 is for the treatment of ovarian cancer, urothelial/bladder cancer, lung cancer (NSCLC), triple-negative breast cancer, head and neck cancer (HNSCC), and gastric/upper gastrointestinal cancer. * Learn more about BT5528 therapy alone and in combination with nivolumab.
Recruiting1 award Phase 1 & 214 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Tennessee Oncology PLLC?
Tennessee Oncology PLLC is a medical facility located in Nashville, Tennessee. This center is recognized for care of Breast Cancer, Lung Cancer, Cystic Tumor, Non-Small Cell Lung Cancer, Solid Tumors and other specialties. Tennessee Oncology PLLC is involved with conducting 296 clinical trials across 179 conditions. There are 11 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and David R. Spigel, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.